[ad_1]
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange, July 29, 2019.
Brendan McDermid | Reuters
Pfizer reported Tuesday first-quarter earnings that beat Wall Street estimates and reaffirmed its full-year revenue guidance as the drugmaker works to develop a vaccine to prevent the coronavirus.
The drugmaker reported adjusted earnings of 80 cents per share, 7 cents higher than Wall Street analysts polled by Refinitiv expected. The company reported revenue of $12 billion, higher than the $11.8 billion expected.
Shares of the company were up nearly 2% in premarketing trading.
Pfizer estimates it can potentially produce millions of coronavirus vaccine doses by the end of this year.
This is a developing story. Please check back for updates.
